![Communication problems - should I leave? [closed]](https://cdn.sstatic.net/Sites/workplace/Img/apple-touch-icon@2.png?v=d39b333f5c58)
Life sciences: Primed for an increase
M&A activity in the life science sector fell in 2024, but several factors, including pent-up demand and the state of companies’ pipelines, point to a strong rebound in dealmaking in 2025.
M&A activity in the life science sector fell in 2024, but several factors, including pent-up demand and the state of companies’ pipelines, point to a strong rebound in dealmaking in 2025.
